What is osteochondroma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Osteochondroma should be managed with a combination of physical examination, plain radiographs, and dedicated MRI for lesions >5-6 cm or in the pelvis/scapula, with consideration of surgical removal for symptomatic lesions or suspected malignant transformation, as the risk of chondrosarcoma is estimated to be around 0.2-5.9% 1.

Key Considerations

  • The diagnosis of osteochondroma is typically confirmed through X-rays, which show the characteristic appearance of a bone growth continuous with the underlying bone's cortex and medullary cavity 1.
  • Multiple hereditary exostoses (HMO) is a condition characterized by the development of multiple osteochondromas, primarily caused by pathogenic variants in the EXT1 or EXT2 genes 1.
  • The risk of malignant transformation into chondrosarcoma is higher in males and individuals with an EXT1 pathogenic variant, and is estimated to occur in 0.2-5.9% of individuals with HMO 1.

Management Recommendations

  • Asymptomatic osteochondromas can be managed with observation, while symptomatic lesions or those with suspected malignant transformation may require surgical removal 1.
  • Physical examination and plain radiographs should be used to monitor osteochondromas, with dedicated MRI considered for lesions >5-6 cm or in the pelvis/scapula 1.
  • The frequency of surveillance should be individualized based on the patient's age, symptoms, and risk factors, with consideration of whole-body MRI (WBMRI) and dedicated brain MRI for patients over 20 years or with symptoms/signs 1.

From the Research

Definition and Characteristics of Osteochondroma

  • Osteochondroma is a common benign bone tumor, presenting as a single or multiple lesions, pedunculated or sessile type, mainly in 1st-2nd decades and mostly in males 2.
  • It is a projection on the external surface of the bone, which can be sessile or pedunculated 3.
  • Osteochondromas may be solitary (solitary osteochondroma, SO) or multiple (multiple osteochondromas MO) 4.

Clinical Manifestations and Complications

  • Clinical manifestations include deformity of bone, compression of surrounding tissue and vascular or neurological compromise 4.
  • Symptoms may eventuate from compression of adjacent vessels or nerves, fractures, osseous deformities, bursa formation, or malignant transformation 3.
  • Pain and/or increase in size of lesions after skeletal maturation were the most common clinical signs of transformation 4.
  • Malignant transformation is a rare but possible complication, more common in multiple osteochondromas (MO) than in solitary cases 3, 4, 5.

Diagnosis and Treatment

  • Surgical excision is the best line of treatment for symptomatic lesions, complications, cosmetic reasons or malignant transformation 2, 3.
  • Excision of the tumor with free margin is the treatment of choice, with local recurrence less than 2% if complete resection is achieved 3.
  • Conservative treatment by observation and yearly radiographs is an option for asymptomatic lesions, especially in pediatric patients 6.
  • Regular self-control and supplementary X-ray imaging or magnetic resonance imaging (MRI) may be needed for follow-up, especially in cases of multiple osteochondromas or lesions located in difficult-to-access anatomical regions 4.

Prognosis and Follow-up

  • The risk of malignant transformation of solitary osteochondromas is generally low, but axial lesions, recurrent osteochondromas, and multiple osteochondromas seem to have an increased risk 4.
  • Follow-up is necessary to monitor for potential complications or malignant transformation, with a recommended frequency of once a year after skeletal maturity for high-risk patients 4.
  • Spontaneous regression of solitary osteochondromas is possible, although rare, and may occur before skeletal maturity or within 3 years of identification 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.